Post-stroke syndrome refers to the collection of symptoms that arise after a stroke. These symptoms result from the brain damage which occurs from a clot in the brain or a hemorrhage in the cranium. When a clot blocks the blood supply, a part of the brain dies, and those specific areas of the brain no longer respond. This is also known as cerebral infarction.

Each part of the brain is responsible for specific actions, which is why patients experience a wide variety of symptoms in the post-stroke period. Depending on the severity of the stroke, symptoms can also vary in intensity. Some of the most common symptoms of post-stroke syndrome include one-sided paralysis., partial blindness, facial drooping, and aphasia (difficulty understanding and speaking words).

Typically, treatment for post-stroke syndrome involves a combination of physical, speech, and occupational therapies. Unfortunately, damaged brain cells do not grow back, and medical science does not currently have a cure to restore complete functionality in post-stroke patients. With that being said, diligent rehabilitation can help patients regain some function. Results vary by individual and depend on the severity of the stroke, as well as the ability to create new neural pathways in the brain.

Regenerative Medicine therapies offer an alternative option with the ability to replace damaged cells and restore lost functions. For example, specific types of stem cells have the potential to help repair the brain after stroke. These cells can aid in neurological recovery and suppress inflammation, both of which are critical in stroke recovery. Moreover, stem cell therapy for stroke has been shown to improve physical functioning and successfully repair damaged areas of the brain. 

The benefits of Regenerative Medicine therapies are not exclusive to post-stroke syndrome and are being studied across a variety of degenerative and chronic conditions, as well as athletic injuries. Regenerative Medicine therapies spur the body’s natural healing abilities to become more efficient, thereby reducing symptoms and improving the quality of life in many individuals.

Regenerative Medicine is still considered an experimental procedure and not approved by the FDA. Patients must consider realistic expectations in their research and possible therapy options.